Cargando…

EVALUATION OF P53, E-CADHERIN, COX-2, AND EGFR PROTEIN IMUNNOEXPRESSION ON PROGNOSTIC OF RESECTED GALLBLADDER CARCINOMA

BACKGROUND: Gallbladder carcinoma presents a dismal prognosis. Choice treatment is surgical resection that is associated a high levels of both morbidity and mortality. Best knowledgement of prognostic factors may result a better selection of patients either for surgical or multimodal treatment. AIM:...

Descripción completa

Detalles Bibliográficos
Autores principales:	PAIS-COSTA, Sergio Renato, FARAH, José Francisco de Matos, ARTIGIANI-NETO, Ricardo, MARTINS, Sandro José, GOLDENBERG, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Colégio Brasileiro de Cirurgia Digestiva 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678687/ https://www.ncbi.nlm.nih.gov/pubmed/25004291 http://dx.doi.org/10.1590/S0102-67202014000200009

Ejemplares similares

GROWTH FACTORS AND COX2 IN WOUND HEALING: AN EXPERIMENTAL STUDY WITH EHRLICH TUMORS
por: SALGADO, Flávio L. L., et al.
Publicado: (2016)

Expression of VEGF and Cox-2 in Patients with Esophageal Squamous Cell Carcinoma
por: Luz, Caio Cesar Floriano, et al.
Publicado: (2018)

EGFR, but not COX-2, protein in resected pancreatic ductal adenocarcinoma is associated with poor survival
por: Fagman, Johan Bourghardt, et al.
Publicado: (2019)

The Cross-Talk Between EGFR and E-Cadherin
por: Ramírez Moreno, Miguel, et al.
Publicado: (2022)

EGFR Expression in Gallbladder Carcinoma in North America
por: Kaufman, Matthew, et al.
Publicado: (2008)

Resected Pleomorphic Carcinoma of the Gallbladder
por: Shimada, Masanari, et al.
Publicado: (2012)

Treatment of Resectable Gallbladder Cancer
por: Vega, Eduardo A., et al.
Publicado: (2022)

COX-2 and EGFR: Partners in Crime Split by Aspirin
por: Patrignani, Paola, et al.
Publicado: (2015)

Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma
por: Du, Peng, et al.
Publicado: (2016)

To Resect or Not to Resect Extrahepatic Bile Duct in Gallbladder Cancer?
por: Gavriilidis, Paschalis, et al.
Publicado: (2017)

Transactivation of EGFR by LPS Induces COX-2 Expression in Enterocytes
por: McElroy, Steven J., et al.
Publicado: (2012)

Immunoexpression of TS, p53, COX2, EGFR, MSH6 and MLH1 biomarkers and its correlation with degree of differentiation, tumor staging and prognostic factors in colorectal adenocarcinoma: a retrospective longitudinal study
por: Batista, Wilson Roberto, et al.
Publicado: (2019)

p53 and Beta-Catenin Expression in Gallbladder Tissues and Correlation with Tumor Progression in Gallbladder Cancer
por: Ghosh, Mila, et al.
Publicado: (2013)

CRITICAL EVALUATION OF LONG-TERM RESULTS OF MALIGNANT HEPATIC TUMORS TREATED BY MEANS CURATIVE LAPAROSCOPIC HEPATECTOMY
por: PAIS-COSTA, Sergio Renato, et al.
Publicado: (2017)

Identification of a new regulation pathway of EGFR and E-cadherin dynamics
por: Proux-Gillardeaux, Veronique, et al.
Publicado: (2021)

Benefit of Adjuvant Chemoradiotherapy in Resected Gallbladder Carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2019)

Survival after extended resections for gallbladder cancer
por: Bhatti, Abu Bakar Hafeez, et al.
Publicado: (2023)

Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth
por: Rea, Katia, et al.
Publicado: (2018)

A case of resected hepatocellular carcinoma with gallbladder metastasis
por: Hanazawa, Takaaki, et al.
Publicado: (2021)

Tumor Protein p53 and K -ras Gene Mutations in Peruvian Patients with Gallbladder Cancer
por: Vidaurre, Tatiana, et al.
Publicado: (2019)

COX-2 regulates E-cadherin expression through the NF-κB/Snail signaling pathway in gastric cancer
por: Chen, Zhaofeng, et al.
Publicado: (2022)

Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation
por: Hattar, Katja, et al.
Publicado: (2012)

Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma
por: Rao, Chinthalapally V., et al.
Publicado: (2015)

EGFR and COX-2 Dual Inhibitor: The Design, Synthesis, and Biological Evaluation of Novel Chalcones
por: Musa, Arafa, et al.
Publicado: (2022)

E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma.
por: Jones, J. L., et al.
Publicado: (1996)

Cadherin-6 type 2, K-cadherin (CDH6) is regulated by mutant p53 in the fallopian tube but is not expressed in the ovarian surface
por: Karthikeyan, Subbulakshmi, et al.
Publicado: (2016)

Gallbladder-associated symptomatic hepatic choristoma: Should you resect?
por: Termos, Salah, et al.
Publicado: (2017)

Two cases of resected gallbladder carcinosarcoma with a contrasting course
por: Kato, Toru, et al.
Publicado: (2022)

HIF-1α、COX-2和E-cadherin在肺腺癌的表达及临床意义
Publicado: (2011)

Stabilization of E-cadherin adhesions by COX-2/GSK3β signaling is a targetable pathway in metastatic breast cancer
por: Balamurugan, Kuppusamy, et al.
Publicado: (2023)

Endoscopic Transpapillary Gallbladder Drainage for Acute Cholecystitis using Two Gallbladder Stents (Dual Gallbladder Stenting)
por: Sobani, Zain A, et al.
Publicado: (2021)

EGFR-targeted fluorescent imaging using the da Vinci® Firefly™ camera for gallbladder cancer
por: Choi, Jung Ha, et al.
Publicado: (2022)

p53, Cyclin-D1, β-catenin, APC and c-myc in Tumor Tissue from Colorectal and Gastric Cancer Patients with Suspected Lynch Syndrome by the Bethesda Criteria
por: Marcolino, Tais Fernanda, et al.
Publicado: (2020)

Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR
por: Wang, Dongsheng, et al.
Publicado: (2011)

Reggies/flotillins regulate E-cadherin–mediated cell contact formation by affecting EGFR trafficking
por: Solis, Gonzalo P., et al.
Publicado: (2012)

ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer
por: Geißler, Anna-Lena, et al.
Publicado: (2017)

Analysis of the correlation between P53 and Cox-2 expression and prognosis in esophageal cancer
por: CHEN, JUN, et al.
Publicado: (2015)

Magnolol inhibits growth of gallbladder cancer cells through the p53 pathway
por: Li, Maolan, et al.
Publicado: (2015)

Expression and inhibitory effects of p53-upregulated modulator of apoptosis in gallbladder carcinoma
por: Liu, Zhide, et al.
Publicado: (2021)

Clinicopathological significance of E-cadherin, β-catenin and p53 expression in gastric adenocarinoma
por: Zali, Mohammad Reza, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_klgiji1h0ds2licn3c001do08l